Skip to content
Search

Latest Stories

Submit Guest Post

India becomes third hardest-hit country for virus cases

INDIA announced Monday (6) that it has nearly 700,000 coronavirus cases, taking it past Russia to become the third-hardest-hit nation in the global pandemic.

The health ministry said 697,358 cases had now been recorded, a rise of 24,000 in 24 hours, while Russia has just over 681,000.


The US and Brazil have the highest numbers of cases but India's tally is not expected to peak for several more weeks and experts predict the one million figure will be passed this month.

India has registered 19,963 deaths from the virus, a much lower number than many other badly hit countries.

India's major cities have been worst hit by the pandemic. New Delhi and Mumbai each have about 100,000 cases, with 3,000 dead in the capital and nearly 5,000 in Mumbai.

New Delhi has opened a new 10,000-bed temporary virus hospital while other cities are tightening restrictions on movement to head off a new surge in cases.

The Kerala state capital, Thiruvananthapuram imposed a new lockdown from Monday with public transport shut and only pharmacies allowed to open. The clampdown came after hundreds of new cases were reported across the state, which had been praised for its action to curtail the pandemic.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Weight loss pill

Foundayo is the latest GLP-1 treatment to receive UK approval in tablet form

Representational image: iStock

UK becomes first European nation to approve new weight-loss pill, but NHS access is still pending

  • The UK is the first European country to approve Eli Lilly’s Foundayo pill.
  • The tablet is taken once a day without food or water restrictions.
  • NHS availability will depend on a separate NICE assessment.

The UK has become the first European nation to approve a new daily weight-loss pill, giving patients another option beyond the injectable treatments that have dominated the GLP-1 market.

The Medicines and Healthcare products Regulatory Agency (MHRA) approved Eli Lilly’s orforglipron, sold under the brand name Foundayo, on August 10 for weight management and to improve blood sugar control in adults with type 2 diabetes.

Keep ReadingShow less